Brigid Garelik has been appointed Chief Medical Officer of the Children’s Tumor Foundation
We’re pleased to announce that Brigid Garelik, MD, MPH, has been appointed Chief Medical Officer of the Children’s Tumor Foundation, overseeing the Foundation’s research and clinical initiatives. In this role, Dr. Garelik will set direction for the Foundation’s innovative R&D programs, developing effective clinical and preclinical strategies in order to deliver treatments to patients. She will also direct the Foundation’s educational programs in support of NF healthcare professionals, growing the NF field, and R&D related patient engagement. She will report to the President of the Children’s Tumor Foundation, Annette Bakker, PhD.
Dr. Garelik is an accomplished pediatric oncologist, scientist, and senior level pharma/biotech executive with extensive experience in the healthcare landscape spanning basic research, patient care, and global drug development. She brings to the role broad therapeutic expertise leading teams and in developing novel therapies in small molecules, biologics, and cell and gene therapy, from the preclinical stage to successful approvals and product launch to market. Her prior experience includes 10 plus years as a physician scientist at a large academic medical center followed by 15+ years in oncology clinical development in both global pharmaceutical corporations and biotechnology organizations.
Welcome to the Children’s Tumor Foundation, Dr. Garelik
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023